![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Industry | Biotechnology |
---|---|
Founded | 2014 |
Founder | John Browne |
Headquarters | Dublin , Republic of Ireland |
Area served | Worldwide |
Products | Antimicrobial solutions |
Website |
www |
Kastus Technologies is an Irish multinational nanotechnology company that specialises in patented, visible-light-activated, photocatalytic, antimicrobial coatings. These coatings prevent the growth of bacteria on surfaces such as ceramics, glass, and touchscreens, with no negative side effects for the end user. [1] Founded in Dublin in 2014, Kastus’ antimicrobial coatings were in development for over 10 years as part of a collaboration with Dublin Institute of Technology and the Advanced Materials and Bio Engineering Research (AMBER) Centres. [2]
John Browne, Kastus CEO, founded the company in 2014 in Dublin following 10 years of collaborative research with Dublin Institute of Technology. [3] It was developed out of an increasing demand for a reduction in the spread of antibiotic-resistant infections commonly found on indoor surfaces. In October 2017, the Department of Health published “Ireland’s National Action Plan on Antimicrobial Resistance 2017-2020”, which highlighted the threat antimicrobial resistance poses and the urgent need for new technology to combat this. [4]
In April 2016, the Sligo Institute of Technology, which is funded by Kastus, announced the creation of a non-toxic antimicrobial nanotechnology, which Kastus plans to market globally. [5] [6] This research is supported by a €1.5 million funding investment from Atlantic Bridge. [7] [8]
In 2018, Kastus partnered with Oman-based ceramic tile producer Al Maha Ceramics, which exports to 15 countries in Asia and Africa. The deal saw Kastus use its antimicrobial technology to produce a range of new tiles called iProtect. [9]
In 2019, Kastus partnered with Faytech to enhance their development of touch display manufacturing capabilities. [10]
In 2020, Kastus developed antimicrobial and antiviral technology used on touch screens to prevent the spread of diseases such as COVID-19. [11] The screen technology has been shown to kill up to 99% of harmful bacteria, fungi, and antibiotic-resistant superbugs, including human coronavirus. [12] Kastus was awarded EU funding to further develop and expand these technologies and their applications, [13] and has partnered with companies such as Lenovo, [14] Zagg, [15] and Lavazza [16] for a range of commercial applications for their products.
In 2021, Kastus raised €5.65 million in a Series A round to build out its global commercial team to meet growing demand for its antiviral surface protection technology. [17]
{{
cite journal}}
: Cite journal requires |journal=
(
help)
{{
cite web}}
: |last=
has generic name (
help)
![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Industry | Biotechnology |
---|---|
Founded | 2014 |
Founder | John Browne |
Headquarters | Dublin , Republic of Ireland |
Area served | Worldwide |
Products | Antimicrobial solutions |
Website |
www |
Kastus Technologies is an Irish multinational nanotechnology company that specialises in patented, visible-light-activated, photocatalytic, antimicrobial coatings. These coatings prevent the growth of bacteria on surfaces such as ceramics, glass, and touchscreens, with no negative side effects for the end user. [1] Founded in Dublin in 2014, Kastus’ antimicrobial coatings were in development for over 10 years as part of a collaboration with Dublin Institute of Technology and the Advanced Materials and Bio Engineering Research (AMBER) Centres. [2]
John Browne, Kastus CEO, founded the company in 2014 in Dublin following 10 years of collaborative research with Dublin Institute of Technology. [3] It was developed out of an increasing demand for a reduction in the spread of antibiotic-resistant infections commonly found on indoor surfaces. In October 2017, the Department of Health published “Ireland’s National Action Plan on Antimicrobial Resistance 2017-2020”, which highlighted the threat antimicrobial resistance poses and the urgent need for new technology to combat this. [4]
In April 2016, the Sligo Institute of Technology, which is funded by Kastus, announced the creation of a non-toxic antimicrobial nanotechnology, which Kastus plans to market globally. [5] [6] This research is supported by a €1.5 million funding investment from Atlantic Bridge. [7] [8]
In 2018, Kastus partnered with Oman-based ceramic tile producer Al Maha Ceramics, which exports to 15 countries in Asia and Africa. The deal saw Kastus use its antimicrobial technology to produce a range of new tiles called iProtect. [9]
In 2019, Kastus partnered with Faytech to enhance their development of touch display manufacturing capabilities. [10]
In 2020, Kastus developed antimicrobial and antiviral technology used on touch screens to prevent the spread of diseases such as COVID-19. [11] The screen technology has been shown to kill up to 99% of harmful bacteria, fungi, and antibiotic-resistant superbugs, including human coronavirus. [12] Kastus was awarded EU funding to further develop and expand these technologies and their applications, [13] and has partnered with companies such as Lenovo, [14] Zagg, [15] and Lavazza [16] for a range of commercial applications for their products.
In 2021, Kastus raised €5.65 million in a Series A round to build out its global commercial team to meet growing demand for its antiviral surface protection technology. [17]
{{
cite journal}}
: Cite journal requires |journal=
(
help)
{{
cite web}}
: |last=
has generic name (
help)